P

Pillar Clinical Research | Richardson, TX

Research site

(Unclaimed)

Location

630 North Coit Road Suite 2200, Richardson, Texas, United States of America

Site insights

Top conditions

Top treatments

SEP-363856

KarXT

Brexpiprazole

LB-102

Cariprazine

MK-8189

Glucose

BHV-7000

Risperidone

Roluperidone

Parent organization

This site is a part of Pillar Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 52 total trials

52-week Open Label Safety-Tolerability Study (NOVA3)

Phase 3, open label, multicenter study designed to assess the long term safety and tolerability of LB-102 for the treatment of adult patients with st...

Not yet enrolling

Schizophrenia

Drug: LB-102

A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder

This is a Phase 2B clinical study evaluating the effectiveness and safety of SP-624 as compared to placebo in the treatment of adults with Major Depr...

Active, not recruiting

Major Depressive Disorder

Drug: SP-624

Drug: Placebo

An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia

This is a Phase 3, multicenter, 52-week, outpatient, open-label extension (OLE) study to evaluate the long-term safety and tolerability of adjunctive...

Enrolling

Schizophrenia

Drug: Xanomeline and Trospium Chloride Capsules

Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE. (Illuminate1)

Phase II study for patients with Bipolar 1 Disorder experiencing major depressive episode. Patient eligible for enrollment will be randomized (like f...

Enrolling

Bipolar I Disorder

Other: Placebo

Drug: LB-102